New cardiovascular risk determinants do exist and are clinically useful

Area of Science:

• Cardiology
• Epidemiology
• Biostatistics

Background:

• The Interheart study indicated nine conventional risk factors explain over 90% of premature myocardial infarction.
• This finding might be misinterpreted, suggesting limited impact for novel cardiovascular risk factors.
• Studies on new risk factors often conclude they don't improve cardiovascular disease (CVD) risk prediction.

Purpose of the Study:

• To clarify the ongoing relevance of identifying new causes of CVD.
• To address the potential misinterpretation of existing research on CVD risk factors.
• To highlight limitations in statistical methodologies used for assessing CVD risk prediction.

Main Methods:

• Conceptual analysis of existing cardiovascular disease (CVD) research.
• Critique of statistical approaches in evaluating risk prediction models.
• Discussion on the interpretation of findings from large-scale epidemiological studies.

Main Results:

• The contribution of novel risk factors to CVD causality may be underestimated.
• Inappropriate statistical methods can lead to the incorrect conclusion that new risk factors do not improve prediction.
• The search for new CVD causes and improved risk prediction strategies remains a critical area of research.

Conclusions:

• Searching for novel cardiovascular disease (CVD) causes is essential for advancing medical understanding.
• Current statistical methodologies for risk prediction require re-evaluation to accurately assess the value of new biomarkers.
• Further research is needed to refine our understanding of CVD etiology and enhance predictive models.